Scribd Logo
Upload

Welcome to Scribd!

    • 84 views

    Ark Genomic Revolution Multisector Etf Arkg Holdings

    Uploaded by

    Axel Onsager

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Ark Genomic Revolution Multisector Etf Arkg Holdings

    Uploaded by

    Axel Onsager
    84 views2 pages

    Original Title

    Ark Genomic Revolution Multisector Etf Arkg Holdings (1)

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    84 views2 pages

    Ark Genomic Revolution Multisector Etf Arkg Holdings

    Uploaded by

    Axel Onsager

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 2

    ARK GENOMIC REVOLUTION MULTI SECTOR ETF (ARKG) HOLDINGS

    As of 12/24/2020

    Company Ticker CUSIP Shares Market Value($) Weight(%)

    1 PACIFIC BIOSCIENCES OF CALIF PACB 69404D108 20,016,038 543,035,110.94 6.93


    2 CRISPR THERAPEUTICS AG CRSP H17182108 2,853,841 480,872,208.50 6.14
    3 TWIST BIOSCIENCE CORP TWST 90184D100 2,861,354 469,376,510.16 5.99
    4 ARCTURUS THERAPEUTICS HOLDIN ARCT UQ 03969T109 3,944,931 387,116,079.03 4.94
    5 TELADOC HEALTH INC TDOC 87918A105 1,782,499 370,670,667.05 4.73
    6 INVITAE CORP NVTA 46185L103 6,195,551 291,624,585.57 3.72
    7 CAREDX INC CDNA 14167L103 3,750,259 285,882,243.57 3.65
    8 PERSONALIS INC PSNL 71535D106 6,756,422 280,323,948.78 3.58
    9 MORGAN STANLEY GOVT INSTL 8035 X9USDMORS 273,798,203 273,798,203.14 3.49
    10 IOVANCE BIOTHERAPEUTICS INC IOVA 462260100 5,433,454 269,227,645.70 3.44
    11 FATE THERAPEUTICS INC FATE 31189P102 2,678,951 266,555,624.50 3.40
    12 EXACT SCIENCES CORP EXAS 30063P105 1,898,640 264,974,198.40 3.38
    13 PURE STORAGE INC - CLASS A PSTG 74624M102 7,986,709 191,521,281.82 2.44
    14 CELLECTIS - ADR CLLS 15117K103 6,051,067 183,952,436.80 2.35
    15 ROCHE HOLDINGS LTD-SPONS ADR RHHBY 771195104 3,895,195 165,740,547.25 2.11
    16 VERTEX PHARMACEUTICALS INC VRTX 92532F100 699,216 163,938,183.36 2.09
    17 REGENERON PHARMACEUTICALS REGN 75886F107 316,640 154,814,795.20 1.98
    18 EDITAS MEDICINE INC EDIT 28106W103 1,816,492 151,731,576.76 1.94
    19 ALPHABET INC-CL A GOOGL 02079K305 85,617 148,473,576.72 1.89
    20 INCYTE CORP INCY 45337C102 1,645,760 143,790,051.20 1.83
    21 NOVARTIS AG-SPONSORED ADR NVS 66987V109 1,568,236 138,867,297.80 1.77
    22 INTELLIA THERAPEUTICS INC NTLA 45826J105 2,184,178 135,724,820.92 1.73
    23 BERKELEY LIGHTS INC BLI 084310101 1,282,210 132,554,869.80 1.69
    24 CASTLE BIOSCIENCES INC CSTL 14843C105 1,833,021 130,712,727.51 1.67
    25 TAKEDA PHARMACEUTIC-SP ADR TAK UN 874060205 6,726,762 121,821,659.82 1.55
    26 VERACYTE INC VCYT 92337F107 2,159,332 120,490,725.60 1.54
    27 IONIS PHARMACEUTICALS INC IONS 462222100 2,010,382 119,979,597.76 1.53
    28 ACCOLADE INC ACCD 00437E102 2,186,480 114,615,281.60 1.46
    29 SCHRODINGER INC SDGR 80810D103 1,288,683 108,184,937.85 1.38
    30 ADAPTIVE BIOTECHNOLOGIES ADPT 00650F109 1,426,947 89,226,995.91 1.14
    31 SERES THERAPEUTICS INC MCRB 81750R102 3,561,614 86,475,987.92 1.10
    32 CODEXIS INC CDXS 192005106 3,658,943 82,948,237.81 1.06
    33 VEEVA SYSTEMS INC-CLASS A VEEV 922475108 280,181 80,574,451.98 1.03
    34 BEAM THERAPEUTICS INC BEAM 07373V105 923,060 81,081,590.40 1.03
    35 THERMO FISHER SCIENTIFIC INC TMO 883556102 174,981 80,157,046.29 1.02
    36 AQUABOUNTY TECHNOLOGIES AQB 03842K200 8,234,821 77,324,969.19 0.99
    37 COMPUGEN LTD CGEN M25722105 5,735,230 75,303,569.90 0.96
    38 10X GENOMICS INC-CLASS A TXG 88025U109 492,489 74,528,360.37 0.95
    39 PHREESIA INC PHR 71944F106 1,215,401 69,654,631.31 0.89
    40 NANOSTRING TECHNOLOGIES INC NSTG 63009R109 941,462 68,463,116.64 0.87
    41 GUARDANT HEALTH INC GH 40131M109 498,990 66,759,872.10 0.85
    42 CERUS CORP CERS 157085101 8,174,256 65,966,245.92 0.84
    43 SYROS PHARMACEUTICALS INC SYRS 87184Q107 3,167,084 41,425,458.72 0.53
    44 SAREPTA THERAPEUTICS INC SRPT 803607100 224,345 39,267,105.35 0.50
    45 LONGVIEW ACQUISITION CORP-A LGVW 543195101 1,392,657 29,329,356.42 0.37
    46 908 DEVICES INC MASS 65443P102 404,796 27,493,744.32 0.35
    47 PLURISTEM THERAPEUTICS INC PSTI 72940R300 3,517,308 25,359,790.68 0.32
    48 SURFACE ONCOLOGY INC SURF 86877M209 2,174,856 20,943,863.28 0.27
    49 EVOGENE LTD EVGN M4119S104 4,594,499 20,261,740.59 0.26
    50 REPARE THERAPEUTICS INC RPTX 760273102 557,117 18,496,284.40 0.24
    51 ORGANOVO HOLDINGS INC ONVO 68620A203 375,102 5,986,627.92 0.08

    The principal risks of investing in ARK ETFs include equity, market, management and non-diversification risks, as well as fluctuations in market
    value and net asset value ("NAV"). Investors should carefully consider the investment objectives and risks as well as charges and expenses of
    an ETF before investing. This and other information are contained in each ETF's prospectus, which may be obtained by contacting the ETF's
    transfer agent The Bank of New York Mellon or by clicking here. Please read the prospectus carefully before you invest.
    The market price of ETF shares may differ significantly from their NAV during periods of market volatility. ETF shares may only be redeemed
    directly with the ETF at NAV by Authorized Participants, in very large creation units.
    Holdings are subject to change without notice and are not a recommendation to buy or sell any security.
    There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain
    unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur
    brokerage costs that detract significantly from investment returns.
    ©2020, ARK Investment Management LLC. All content is original and has been researched and produced by ARK Investment Management LLC
    unless otherwise stated. No part of this content may be reproduced in any form, or referred to in any other publication, without the express
    written permission of ARK Investment Management LLC. All statements made regarding companies, securities or other financial information on
    this site or any sites or articles relating to ARK Investment Management LLC are strictly beliefs and points of view held by ARK Investment
    Management and are subject to change without notice. Information contained herein has been obtained from sources believed to be reliable, but
    not guaranteed. This material has been distributed for informational purposes only and should not be considered as investment advice or a
    recommendation of any particular security, strategy or investment product.

    You might also like